SCHEMBL3513447

SCHEMBL3513447

[c]1ccnc(N2CCCC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
USP2 O75604 2/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CHKA P35790 1/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 1/20 0.34
CYP2C19 P33261 2/20 0.34
ACHE P22303 2/20 0.34
CCNT1 O60563 2/20 0.34
CCNA2 P20248 2/20 0.34
CDK2 P24941 2/20 0.34
CDK9 P50750 2/20 0.34
HRH1 P35367 1/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2322094 0.98 CCNT1 (0.35) KDM4EUSP2POLBALDH1A1CHKA
SCHEMBL5596259 0.86 LMNA (0.50) KDM4EUSP2POLBALDH1A1LMNA
SCHEMBL11101846 0.82 ACHE (0.38) KDM4EUSP2POLBALDH1A1LMNA
SCHEMBL5597094 0.82 HTR3A (0.42) ACHECCNT1CCNA2CDK2CDK9
SCHEMBL1466733 0.82 ALDH1A1 (0.58) KDM4EUSP2ALDH1A1ACHEHRH1
SCHEMBL1110443 0.82 POLB (0.41) KDM4EPOLBALDH1A1LMNAACHE
SCHEMBL5597095 0.81 KDM4E (0.41) KDM4EALDH1A1LMNAMAPTCYP2C19
SCHEMBL6294824 0.78 ACHE (0.43) KDM4EALDH1A1LMNAMAPTACHE
SCHEMBL5801122 0.78 MAPT (0.66) POLBALDH1A1LMNAMAPTTSHR
SCHEMBL6293414 0.78 CHRNA7 (0.40) KDM4EMAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200071326-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS INC (US) 2020-03-05 US claimed
WO-2018191587-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS, INC. (US) 2018-10-18 WO claimed
EP-1696909-B1 BENZOTHIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES SERONO LAB (CH) 2007-11-14 EP claimed
EP-0580633-A1 HETEROCYCLIC AMINES USEFUL IN THE THERAPY OF ASTHMA AND INFLAMMATION OF THE RESPIRATORY TRACT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1994-02-02 EP claimed
WO-1992018478-A1 HETEROCYCLIC AMINES USEFUL IN THE THERAPY OF ASTHMA AND INFLAMMATION OF THE RESPIRATORY TRACT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1992-10-29 WO claimed
US-20200071326-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS INC (US) 2020-03-05 US disclosed
WO-2018191587-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS, INC. (US) 2018-10-18 WO disclosed
EP-2857388-A1 Azoles containing sulfone Grünenthal GmbH (DE) 2015-04-08 EP disclosed
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 US disclosed
EP-0662957-A1 1,4-DISUBSTITUTED PIPERAZINES USEFUL IN THE THERAPY OF THE ASTHMA AND OF THE INFLAMMATION OF THE RESPIRATORY TRACT BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1995-07-19 EP disclosed
EP-0536169-A1 3H,7H]THIAZOLO 3,4-a]PYRIDINES WITH ANTIASTHMATIC AND ANTIINFLAMMATORY ACTIONS ON THE RESPIRATORY TRACT. BOEHRINGER MANNHEIM ITALIA (IT) 1993-04-14 EP disclosed
US-4435401-A 4-Amino-6,7-dimethoxy-2-(4-heteroaryl-piperazino)quinazoline antihypertensives PFIZER INC. (US) 1984-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071326-A1 TAM KINASE INHIBITORS PIK3CA, MAP3K1, MAP3K5 KDM4E 679/4885USP2 2288/4885POLB 2610/4885
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 KDM4E 1280/4885USP2 2967/4885POLB 4228/4885
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 KDM4E 1280/4885USP2 2967/4885POLB 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.